Pfizer Health Services Research Grant 2025

Apply before: January 30, 2025

The Pfizer Research Grant Request for Proposals (RFP) for Health Services Research to Improve Management of Metastatic Breast Cancer (mBC) Patients Treated with Tucatinib invites organizations to submit proposals focused on improving therapy management for patients with HER2+ mBC. Specifically, it seeks projects that assess and implement approaches to enhance patients’ understanding, adherence, quality of life, and symptom management while receiving a combination treatment of tucatinib, trastuzumab, and capecitabine.

Eligibility

The eligibility criteria for Pfizer Health Services Research Grant 2025 are:

Must be organizations, not individuals.
The Principal Investigator (PI) must hold an MD, PhD, or other relevant terminal degrees, and be affiliated with the applying institution.
The institution must be legally able to receive funds directly from Pfizer.
Projects should aim to improve patient care and outcomes through innovative and community-accessible approaches. These may include:
- Digital tools (e.g., apps) for monitoring.
- Educational tools for safety profiles and adverse event management.
- Multidisciplinary management models involving primary care providers, oncology nurses, or call centers.

The Value-Adding Paradox: How Spending Less Can Actually Make Your Business More Valuable?

Benefits

The benefit of Pfizer Health Services Research Grant 2025 are:

Funding Support: Grants up to $250,000 per project.
Global Reach: Open to organizations worldwide.
Flexible Duration: Projects can last up to 18 months.
Enhance Patient Care: Focuses on improving therapy management for metastatic breast cancer (HER2+).
Innovation: Supports innovative approaches to improve adherence, quality of life, and symptom management.
Networking Opportunities: Connect with global researchers and institutions.
Career Advancement: Opportunities for publications and presentations at conferences.
Institutional Resources: Leverage organizational expertise and infrastructure.
Impactful Research: Contribute to advancing clinical practices and patient outcomes.
No Requirement for Drug Supply: Funding does not cover tucatinib drug supply.

Application process

Click here to Apply.

For more Interesting Content and other opportunities, Visit and Follow/Like Us On Facebook, Twitter, LinkedIn, and Instagram.

Afghanistan, Albania, Algeria, Andorra, Angola, Antigua and Barbuda, Argentina, Armenia, Aruba, Australia, Austria, Azerbaijan, Bahamas, The, Bahrain, Bangladesh, Barbados, Belarus, Belgium, Belize, Benin, Bhutan, Bolivia, Bosnia and Herzegovina, Botswana, Brazil, Brunei, Bulgaria, Burkina Faso, Burma, Burundi, Cambodia, Cameroon, Canada, Cabo Verde, Central African Republic, Chad, Chile, China, Colombia, Comoros, Congo, Cook Islands, Costa Rica, Cote d'Ivoire, Croatia, Cuba, Curacao, Cyprus, Czechia, Denmark, Djibouti, Dominica, Dominican Republic, East Timor, Ecuador, Egypt, El Salvador, Equatorial Guinea, Eritrea, Estonia, Eswatini, Ethiopia, Fiji, Finland, France, Gabon, Gambia, The, Georgia, Germany, Ghana, Greece, Grenada, Guatemala, Guinea, Guinea-Bissau, Guyana, Haiti, Holy See, Honduras, Hong Kong, Hungary, Iceland, India, Indonesia, Iran, Iraq, Ireland, Israel, Italy, Jamaica, Japan, Jordan, Kazakhstan, Kenya, Kiribati, North Korea, South Korea, Kosovo, Kuwait, Kyrgyzstan, Laos, Latvia, Lebanon, Lesotho, Liberia, Libya, Liechtenstein, Lithuania, Luxembourg, Macau, Madagascar, Malawi, Malaysia, Maldives, Mali, Malta, Marshall Islands, Mauritania, Mauritius, Mexico, Micronesia, Moldova, Monaco, Mongolia, Montenegro, Morocco, Mozambique, Namibia, Nauru, Nepal, Netherlands, New Zealand, Nicaragua, Niger, Nigeria, North Macedonia, Norway, Oman, Pakistan, Palau, Palestinian Territories, Panama, Papua New Guinea, Paraguay, Peru, Philippines, Poland, Portugal, Qatar, Romania, Russia, Rwanda, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Samoa, San Marino, Sao Tome and Principe, Saudi Arabia, Senegal, Serbia, Seychelles, Sierra Leone, Singapore, Sint Maarten, Slovakia, Slovenia, Solomon Islands, Somalia, South Africa, South Sudan, Spain, Sri Lanka, Sudan, Suriname, Swaziland (See Eswatini), Sweden, Switzerland, Syria, Taiwan, Tajikistan, Tanzania, Thailand, Timor-Leste, Togo, Tonga, Trinidad and Tobago, Tunisia, Turkey, Turkmenistan, Tuvalu, Uganda, Ukraine, United Arab Emirates, United Kingdom, United States, Uruguay, Uzbekistan, Vanuatu, Venezuela, Vietnam, Yemen, Zambia, Zimbabwe

Theme	: Health Services
Applicant Country	: WorldWide
For more information	: Pfizer

Erasmus Mundus Design Measures

Apply before: February 13, 2025 December 21, 2024

Ingenious Training grants

Apply before: February 14, 2025 November 13, 2024

Call for Proposals on Sustainable Health and Social Care Systems for Elderly

Apply before: February 20, 2025 December 24, 2024

Agrifood and Retail SMEs – Renewable Energy Communities

Apply before: February 20, 2025 December 24, 2024

Wilkes Climate Launch Prize 2025

Apply before: February 28, 2025 December 25, 2024

Snowflake Startup Challenge

Apply before: March 1, 2025 November 27, 2024

Bluegrass AgTech Development Corp Challenge Grant Program

Apply before: March 1, 2025 December 25, 2024

Sustainability Fund

Apply before: March 5, 2025 December 25, 2024